쥴릭파마, 룬드벡과 신경정신 건강 솔루션 파트너십 확대
This expanded partnership is crucial for improving access to specialized neuro-psychiatric treatments across Asia, a region with significant unmet needs in mental health.
Expanded partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia.
쥴릭파마는 아시아 전역에서 신경정신 건강 솔루션의 상업화를 강화하기 위해 룬드벡과의 파트너십을 확대했습니다. 이번 협력을 통해 쥴릭파마는 광범위한 유통망과 시장 전문성을 활용하여 신경학적 및 정신과적 질환에 대한 혁신적인 치료법을 더 많은 환자들에게 제공할 예정입니다. 확대된 파트너십은 이 지역에서 전문화된 헬스케어 솔루션에 대한 접근성을 향상시키는 것을 목표로 합니다.
This expanded partnership is crucial for improving access to specialized neuro-psychiatric treatments across Asia, a region with significant unmet needs in mental health. By combining Lundbeck's innovative therapies with Zuellig Pharma's robust commercialization capabilities, more patients will benefit from advanced healthcare solutions, addressing a critical public health challenge and fostering better patient outcomes.
The expanded partnership directly addresses the growing need for neuro-psychiatric health solutions in APAC, leveraging Zuellig Pharma's regional reach to improve access to specialized treatments for a significant patient population.
Where this signal fits in the broader landscape.
No recent signals tracked yet.
https://www.zuelligpharma.com/news-insights/Zuellig-Pharma-expands-partnership-with-Lundbeck-to-support-commercialization-of-neuro-psychiatric-health-solutions-in-Asia
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
로그인